Trials / Completed
CompletedNCT04067583
A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe
Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 454 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information related to physician characteristics and experience with Aflibercept, as well as assess physicians' knowledge and understanding of storage and preparation, proper injection technique, and the risks associated with Aflibercept injection into the eye (intravitreal injection). Analysis will be done using descriptive statistics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Physician questionnaire | This is a one-time cross-sectional survey of physicians, conducted electronically; there are no in person visits |
Timeline
- Start date
- 2019-10-08
- Primary completion
- 2020-04-15
- Completion
- 2020-04-23
- First posted
- 2019-08-26
- Last updated
- 2021-04-08
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04067583. Inclusion in this directory is not an endorsement.